Ginkgo Bioworks Holdings Inc Share Price Today: Live Updates & Key Insights

Ginkgo Bioworks Holdings Inc share price today is $6.71, up -2.89%. The stock opened at $6.89 against the previous close of $6.91, with an intraday high of $7.06 and low of $6.66.

Ginkgo Bioworks Holdings Inc Share Price Chart

Ginkgo Bioworks Holdings Inc

us-stock
To Invest in {{usstockname}}
us-stock

Ginkgo Bioworks Holdings Inc Share Price Performance

$6.71 -0.0289(-2.89%) DNA at 23 Mar 2026 12:44 PM Biotechnology
Lowest Today 6.66
Highest Today 7.06
Today’s Open 6.89
Prev. Close 6.91
52 Week High 17.58
52 Week Low 5.00
Day’s Range: Low 6.66 High 7.06
52-Week Range: Low 5.00 High 17.58
1 day return -
1 Week return -0.59
1 month return -24.23
3 month return -23.37
6 month return -44.09
1 year return -12.61
3 year return +450.81
5 year return -33.13
10 year return -

Ginkgo Bioworks Holdings Inc Institutional Holdings

Viking Global Investors LP 5.78

BlackRock Inc 5.52

Vanguard Group Inc 4.68

Baillie Gifford & Co Limited. 3.86

Erste Asset Management GmbH 3.23

L&G Artificial Intelligence ETF 2.88

Anchorage Advisors, LLC 2.82

Legal & General Group PLC 2.55

Vanguard Total Stock Mkt Idx Inv 2.22

Scottish Mortgage Ord 1.99

Bank of America Corp 1.73

Forbes J M & Co 1.68

iShares Russell 2000 ETF 1.64

Geode Capital Management, LLC 1.61

State Street Corp 1.51

The Goldman Sachs Group Inc 1.33

SB INVESTMENT ADVISERS (UK) LTD 0.99

Exor Investments (UK) LLP 0.81

Vanguard Institutional Extnd Mkt Idx Tr 0.76

Fidelity Small Cap Index 0.66

Charles Schwab Investment Management Inc 0.58

Stt Strt®SPDR®S&PKenshoNwEcosComposETF 0.57

Exchange Traded Concepts, LLC 0.56

Robo Global® Artificial Intelligence ETF 0.56

PIMCO RAE US Small 0.55

PIMCO RAE US Small Instl 0.55

Ensign Peak Advisors Inc 0.53

iShares Russell 2000 Value ETF 0.53

Northern Trust Corp 0.53

Morgan Stanley - Brokerage Accounts 0.52

iShares Biotechnology ETF 0.51

LLBH Private Wealth Management, LLC 0.45

Invesco RAFI US 1500 Small-Mid ETF 0.39

State St Russell Sm/Mid Cp® Indx SL Cl I 0.35

Schwab US Small-Cap ETF™ 0.35

Vanguard Russell 2000 ETF 0.32

Vanguard US Momentum Factor ETF 0.30

Fidelity Extended Market Index 0.28

Vanguard Explorer Inv 0.25

State St Russell Sm Cap® Indx SL Cl I 0.22

Ginkgo Bioworks Holdings Inc Market Status

Strong Buy: 1

Buy: 0

Hold: 1

Sell: 3

Strong Sell: 1

Ginkgo Bioworks Holdings Inc Fundamentals

Market Cap 415.51 M

PB Ratio 0.817

PE Ratio 0.0

Enterprise Value 432.78 M

Total Assets 1119.70 M

Volume 1490775

Ginkgo Bioworks Holdings Inc Company Financials

Annual Revenue FY24:227043000 227.0M, FY23:314985000 315.0M, FY22:477706000 477.7M, FY21:313837000 313.8M, FY20:76657000 76.7M

Annual Profit FY24:188494000 188.5M, FY23:237373000 237.4M, FY22:273490000 273.5M, FY21:184147000 184.1M, FY20:61046000 61.0M

Annual Net worth FY24:-547029000 -547.0M, FY23:-856643000 -856.6M, FY22:-2106372000 -2106.4M, FY21:-1836642000 -1836.6M, FY20:-126723000 -126.7M

Quarterly Revenue Q3/2025:38837000 38.8M, Q2/2025:49604000 49.6M, Q1/2025:48318000 48.3M, Q3/2024:89046000 89.0M, Q2/2024:56206000 56.2M

Quarterly Profit Q3/2025:26035000 26.0M, Q2/2025:34782000 34.8M, Q1/2025:36271000 36.3M, Q3/2024:79059000 79.1M, Q2/2024:25155000 25.2M

Quarterly Net worth Q3/2025:-80755000 -80.8M, Q2/2025:-60300000 -60.3M, Q1/2025:-90957000 -91.0M, Q3/2024:-56403000 -56.4M, Q2/2024:-217181000 -217.2M

About Ginkgo Bioworks Holdings Inc & investment objective

Company Information Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Organisation Biotechnology

Employees 485

Industry Biotechnology

CEO Dr. Jason Kelly Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Ginkgo Bioworks Holdings Inc FAQs

What is the share price of Ginkgo Bioworks Holdings Inc today?

The current share price of Ginkgo Bioworks Holdings Inc is $6.71.

Can I buy Ginkgo Bioworks Holdings Inc shares in India?

Yes, Indian investors can buy Ginkgo Bioworks Holdings Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Ginkgo Bioworks Holdings Inc shares in India?

You can easily invest in Ginkgo Bioworks Holdings Inc shares from India by:

Can I buy fractional shares of Ginkgo Bioworks Holdings Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Ginkgo Bioworks Holdings Inc?

Ginkgo Bioworks Holdings Inc has a market cap of $415.51 M.

In which sector does Ginkgo Bioworks Holdings Inc belong?

Ginkgo Bioworks Holdings Inc operates in the Biotechnology sector.

What documents are required to invest in Ginkgo Bioworks Holdings Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Ginkgo Bioworks Holdings Inc?

The PE ratio of Ginkgo Bioworks Holdings Inc is N/A and the PB ratio is 0.82.